BERLIN (Reuters) -German pharmaceutical group Bayer announced on Tuesday a deal worth up to $1.3 billion with Kumquat ...

Under the global exclusive license deal, Kumquat will be responsible for the Phase 1a study of its inhibitor and Bayer will ...

Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to ...

Democratic State Sen. Rosemary Bayer of West Bloomfield announced Monday that she will not seek reelection in what will be a ...

For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat ...

Bayer (BAYRY) stock falls as the company's better-than-expected Q2 2025 results are overshadowed by a disappointing ...

Another Massachusetts biotech has reached the end of the road. | Another Massachusetts biotech has reached the end of the ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

An announcement from Board of Education President Steven Blair on Friday said Mike Dominguez resigned July 31 to "pursue ...